Lupin to acquire Medisol for 18 million Euros

8 May 2023 , 09:59 AM

 Lupin will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160 crore). The company has entered  into a definitive agreement to acquire the entire share capital of Medisol, subject to approval from the French Ministry of Economy and Finance. 

The company has acquired Medisol in EUR 18 million with upfront EUR 14.5 million plus earn-outs up to EUR 3.5 million, it added in the statement.

Medisol, founded in 2011 is specialises in generics injectable products and is engaged in developing and commercialising its products in France’s pharmacies and hospitals. 

The company said in a statement, “With this acquisition, Lupin will gain access to Medisol’s portfolio of seven injectable products across four therapeutic areas, including pain management, anti-inflammatory, cardiovascular diseases, and obstetrics.”

Lupin President – EMEA Thierry Volle said, “Medisol’s unique product portfolio complements our existing range, enabling us to offer our customers an even more robust selection of high-quality products. This acquisition underscores our unwavering commitment to expanding our presence in the EMEA region and providing superior healthcare to patients.”